In this respect, ApoE4-expressing N2a cells pharmacologically treated with GIND25, a small molecule that is able to disrupt ApoE4 domain interaction, reverted some AD-related mitochondrial alterations, namely by restoring Cx IV levels [22]. The gene discussed is APOE; the disease is Alzheimer disease.